Artrya (ASX:AYA), a Perth-based medical technology company utilising artificial intelligence to transform the diagnosis and management of coronary artery disease, has announced the completion of its Share Purchase Plan following a strong investor response.
Artrya share purchase plan closes early after strong investor demand
October 5, 2025 Australian Biotech
Latest Video
New Stories
-
Australians want better access to medical technology, and a clearer pathway to get there
October 28, 2025 - -
Pharmacy Guild backs expanded prescribing rights for optometrists
October 28, 2025 - - Latest News -
PYC reports strong clinical momentum and cash position ahead of key readouts
October 27, 2025 - - Australian Biotech -
Government backs new national push to close bone health testing gap for women
October 27, 2025 - - Latest News -
Leadership change at PolyNovo as long-time Chair steps down
October 27, 2025 - - Australian Biotech -
Cann Group announces major debt restructure and capital raise to strengthen balance sheet
October 27, 2025 - - Australian Biotech -
FDA awards the first-ever national priority vouchers to nine sponsors
October 27, 2025 - - Latest News
